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Background: Chronic subdural hematoma (CSDH) is common clinical entities in neurosurgical practice.
Although several studies have focused on reporting surgical treatment of CSDH in mixed patient pop-
ulations, there are few data concerning the risk factors, complications, and recurrence in the elderly. This
study intended to delineate the perioperative risks, surgical outcomes, and recurrence in elderly patients
with CSDH.
Methods: A retrospective review of 342 age 65 years patients with surgically treated CSDH at our
institution from 2001 to 2011 was conducted. These patients were divided into three groups according to
age (Group A: 65e74 years, Group B: 75e84 years, and Group C: 85e97 years). The demographics,
perioperative risk, surgical results, complications, and recurrence were analyzed. The surgical procedure
included burr-hole craniostomy with a subdural drainage in each patient. The outcomes were evaluated
with initial Glasgow Coma Scale (GCS) and Glasgow Outcome Scale (GOS) at discharge.
Results: The mean age was 77.2  11.4 years, (M:F ratio ¼ 2.2:1). The postoperative neurological status
was improved in all subgroups. The overall outcome was favorable in 83.3%, with median GCS was 15,
and GOS, 1e2 at discharge recovery. The patients with lower initial GCS and higher GOS at discharge had
a higher recurrence rate. The complication and mortality rates did not differ signiﬁcantly within the age
groups.
Conclusion: An observed correlation is apparent between preoperative status and outcome. Burr-hole
craniostomy should be the method of choice for surgical treatment of CSDH.
Copyright  2014, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Chronic subdural hematoma (CSDH), ﬁrst introduced byWepfer
in 1656, is a common disease in neurosurgical practice. It becomes
of growing importance as the number of the elderly people is
increasing steadily in the population. The incidence of the disease
steeply increases with age from 1 case up to 8.2 cases in 100,000 a
year in the 6th and 7th decade of life1e4.tional interest in any of the
ent of Neurosurgery, Mackay
n North Road, Taipei, Taiwan.
i).
tric Emergency & Critical Care MeThe pathophysiology refers to a slowly growing encapsulated
collection of blood and its breakdown products between the dura
mater and the arachnoid4. It is a result of tearing of the bridging
veins, usually as a result of minor trauma with risk factors of brain
atrophy and coagulopathy4,5. The clinical patterns differ widely
between the aged patient groups, from asymptom to impaired
cognitive function, severe neurological deﬁcits, or even life-
threatening herniation3,4. Current treatment of CSDH is usually
accompanied by serious morbidity, mortality (up to 17.0%), and
recurrence rates (4e26%)5. Burr-hole craniostomy is by far the most
advocated and effective surgical strategy for CSDH during the past
20 years6,7.
In this study, we report a 10-year single-center experience with
surgical treatment for CSDH at our institution. The objective of the
study was to delineate the perioperative risks, surgical outcome,
complications, and risk of recurrence in elderly patients with CSDH.dicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Patient demographics.
Groups according to age
Total (n ¼ 342) Group A Group B Group C
Age range, y 65e74 75e84 85e97
No. of patients 129 158 55
Sex
Male 88 (68.2) 116 (73.4) 31 (56.4)
Female 41 (31.8) 42 (26.6) 24 (43.6)
Age, y 71  2.6 78  3.2 88  3.8
Hematoma location
Left side 64 (49.6) 76 (48.1) 27 (49.1)
Right side 40 (31.0) 47 (29.7) 15 (27.3)
Bilateral 25 (19.4) 35 (22.2) 13 (23.6)
History of head injury 75 (58.1) 87 (55.1) 39 (70.9)
Data are presented as n (%) or mean  SD, unless otherwise indicated.
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This study was approved by the Institutional Review Board of
Mackay Memorial Hospital, Taipei, Taiwan.
We retrospectively reviewed the medical records of 342
consecutive patients surgically treated for CSDH at Mackay Me-
morial Hospital, from January 2001 to August 2011.
Patients aged 65 years were included, and the deﬁnitive
diagnosis of CSDH was conﬁrmed by computed tomography (CT).
The clinical record with acute subdural hematomas (presenting
within 3 days of injury or CT scan revealing a uniformly hyperdense
collection) were excluded from the study.
These patients were classiﬁed into three groups according to the
age at presentation; Group A consisted of patients ranging in age
from 65 years to 74 years, Group B consisted of patients ranging in
age from 75 years to 84 years, and Group C consisted of patients
ranging in age from 85 years to 97 years. The study focused on
clinical data concerning age, sex, etiology, clinical symptoms,
concomitant diseases, usage of anticoagulant or thrombolytic
agents, perioperative complications, and outcome.
2.1. Surgery
All the patients were surgical treated with burr-hole cranios-
tomy under general anesthesia. The subdural blood was evacuated
by abundant saline washout followed by placement of a closed
systemdrain. The subdural drainwas left for 3e5 days and removed
on the basis of decreasing drain output and brain re-expansion
veriﬁed by CT scan.
2.2. Outcome assessment
The neurological status was measured according to the initial
Glasgow Coma Scale (GCS) on admission to our department and in
addition to Glasgow Outcome Scale (GOS) at discharge6e8. The
initial consciousness (GCS on admission) was stratiﬁed into three
groups: mildly impaired consciousness was deﬁned as GCS > 12;
moderately impaired as 8  GCS  12; and severely impaired as
GCS < 8.
Postoperative outcome was evaluated with GOS at discharge
and classiﬁed as good recovery (score 1), moderate disability (score
2), severe disability (score 3), persistent vegetative state (score 4),
and death (score 5)7,9. Favorable and unfavorable outcomes were
considered as nonquantitative GOS and deﬁned as GOS scores of 1e
2 and 3e5, respectively9.
2.3. Follow-up
Neurological examination was performed daily during the
hospital stay and at discharge. Postoperative CT was done on
indication, in case of delayed patient recovery and/or suspicion of
failed surgery or recurrence. All the patients were followed-up for
3 months with clinical data available.
2.4. Statistical analysis
The clinical data were analyzed with SPSS version 15.0 (SPSS,
Chicago, IL, USA). Continuous normally distributed variables were
compared univariately with the Student t test and are reported as
mean  standard deviation. For nonnormally distributed variables,
the ManneWhitney U test was used, and data are presented as
median and interquartile range (IQR). Proportions were compared
using the Chi-square and Fisher’s exact tests, and are presented as
percentages in each group. Values of p < 0.05 were considered
statistically signiﬁcant.3. Results
3.1. Patient demographics
A total of 342 consecutive patients underwent burr-hole cra-
niostomy for CSDH at our institution. The patients included 235
males (68.7%) and 107 females (31.3%), ranging in age from 65 years
to 97 years (mean age, 77.2  11.4 years). The demographics char-
acteristics on admission are summarized in Table 1. The age and sex
distribution (Fig. 1) showed a gradual increase in incidence for each
decade with the peak in the 8th decade, and a male predominance
(M:F ratio was 2.2:1) in all subgroups. The location of hematoma
revealed more frequent left sided prevalence between the age
groups as detailed in Table 1.
The etiology of CSDH was determined in 214 patients and
remained unclear in 128 (37.5%) patients. Table 1 shows that head
injury is the most common cause of CSDH between the age groups,
and a history of head injury was usually present in patients of
advanced age. In our series, an incidence of 70.9% was noted in
Group C (age range, 85e97 years; Table 1).
The distribution of clinical symptoms is summarized in Table 2.
The leading clinical symptomwas headache in Group A (34.8%), and
hemiparesis in Group B (38.6%) and Group C (34.5%). The use of
anticoagulant or thrombolytic agents at admission was 17.1% in
Group A,10.7% in Group B, and 21.8% in Group C, but the differences
were not signiﬁcant (Table 3).
The most frequent concomitant disease was hypertension with
58.9% in Group A, 67.7% in Group B, and 83.6% in Group C followed
by coronary artery disease with 28.5% in Group B and 27.2% in
Group C, and atrial ﬁbrillation with 28.5% in Group B and 25.4% in
Group C. Other pathologies are detailed in Table 4.
3.2. Outcome
The overall outcome in our study was favorable. After surgical
treatment, the mean neurological status improved in all three
groups (resumption of normal life in 73.6% of the patients). The
median GCS on admission was 14 (IQR, 11e15); 75.7% of the pa-
tients had a GCS > 12, 14.9% had a GCS 8e12, and 9.38% had a
GCS < 8 (Table 5).
At discharge, the median GCS was 15 (IQR, 14e15) with favor-
able outcome; GOS: 1e2, good recovery was achieved in 88.4% of
Group A, 77.2% of Group B, and 71% of Group C (Fig. 2). Most of the
patients (83.3%) had a very good recovery as measured by the GOS.
3.3. Recurrence
The overall recurrence rate was 11.9%. Although men had a
higher recurrence rate, the difference was not signiﬁcant. Age of
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Fig. 1. Age and sex distribution of 342 patients with chronic subdural hematoma,
showing a male predominance between the age groups and a gradual increase in
incidence for each decade with the peak in the 8th decade.
Table 3
Complications, recurrence rate and preoperative anticoagulant therapy.
Groups according to age
Total (n ¼ 342) Group A Group B Group C
Age range, y 65e74 75e84 85e97
No. of patients 129 158 55
Complications, n (%)
Total 7 (5.4) 6 (3.8) 5 (9.1)
Intracerebral bleeding 2 (1.5) 1 (0.6) 0 (0.0)
Acute subdural hematoma 1 (0.8) 2 (1.3) 3 (5.5)
Epidural hematoma 2 (1.5) 0 (0.0) 0 (0.0)
Cerebral infarction 1 (0.8) 1 (0.6) 2 (3.6)
Infection 1 (0.8) 2 (1.3) 0 (0.0)
Recurrence rate, n (%) 15 (11.6) 24 (15.1) 2 (3.6)
Anticoagulant therapy, n (%) 22 (17.1) 17 (10.7) 12 (21.8)
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recurrence (Table 5).
The patients with a lower GCS scores on admission and higher
GOS scores at discharge had a signiﬁcant association with higher
recurrence rates (p < 0.001). A medical history of diabetes mellitus
was observedmore often in the recurrence group (27.5%) compared
with the nonrecurrence group (12.3%; p ¼ 0.01; Table 5).
3.4. Complications
Complications included intracranial hemorrhage, acute sub-
dural hematoma, extradural hematoma, stroke, and infection, as
detailed in Table 3. The postoperative complications occurred more
often in the recurrence group (14.63%) compared with the non-
recurrence group (3.98%; p ¼ 0.001; Table 5). Even though the
mean age was higher in patients who experienced complications
(76  13 years vs. 72  13.6 years; p ¼ 0.72), the overall compli-
cation rate (5.26%) did not differ signiﬁcantly between the age
groups.
3.5. Mortality
The mortality rate was 1.55% in Group A, 1.9% in Group B, and
5.45% in Group C. The overall mortality was 2.34% without signiﬁ-
cant difference between the age groups.
4. Discussion
CSDH is a common clinical entity in neurosurgical practice.
Although most of the published literature is focused on reporting
surgical treatment of CSDH in mixed patient populations10e13,Table 2
Clinical symptoms at admission.
Groups according to age
Total (n ¼ 342) Group A Group B Group C
Age range, y 65e74 75e84 85e97
No. of patients 129 158 55
Symptoms, n (%)
Absence of symptoms 3 (2.3) 11 (6.9) 1 (1.8)
Headache 45 (34.8) 16 (10.1) 0 (0.0)
Hemiparesis 38 (29.5) 61 (38.6) 19 (34.5)
Speech disturbance 18 (13.9) 23 (14.6) 17 (30.9)
Seizures 5 (3.8) 1 (0.6) 0 (0.0)
Alterations in mental
state
8 (6.2) 14 (8.8) 8 (14.5)
Consciousness
disturbance
2 (1.6) 21 (13.2) 8 (14.5)
Vertigo 10 (7.6) 11 (6.9) 2 (3.6)there are few data concerning the factors that might inﬂuence the
outcome and risk of recurrence in elderly patients.4.1. Etiology and clinical presentation
With increasing age, brain atrophy, and enlarging subdural
space, a relatively minor trauma may result in subdural bleeding.
The pertinent literature revealed that a head injury is the most
common cause of CSDH14. Baechli et al14 reported on 354 patients
and found that there is a peak in incidence of falls in bothmales and
females aged between 75 years and 79 years. This is consistent with
our ﬁndings, which revealed trauma as the major cause for CSDH.
There was a trend towards a higher risk of falls in older patients
(70.9% in Group C vs. 58.1% in Group A).
In our series, the leading clinical symptoms were headache in
Group A and focal neurological deﬁcits such as hemiparesis asso-
ciated with gait disturbance in Groups B and C. These ﬁndings are
consistent with the data published by Santarius et al15 and Gela-
bert-Gonzáles et al16. In Group C of the present study, the most
common symptom was hemiparesis and speech disturbance, e.g.,
aphasia. The high rate of aphasia in the present series might be
explained by a high incidence of left-sided hematomas (49.6% in
Group A, 48.1% in Group B, and 49.1% in Group C). However, there
were no deﬁnite differences observed in relation to the age-groups.4.2. Outcome
In the present study, a favorable outcome was achieved in 83.3%
overall, the postoperative neurological status improved in all three
groups (recovery of normal life in 73.6% of the patients). Most pa-
tients had a very good recovery as measured by the GOS. There was
a favorable outcome in 71% of the patients aged >85 years. TheTable 4
Summary of concomitant diseases.
Groups according to age
Total (n ¼ 342) Group A Group B Group C
Age range, y 65e74 75e84 85e97
No. of patients 129 158 55
Concomitant
diseases, n (%)
Hypertension 76 (58.9) 107 (67.7) 46 (83.6)
Coronary artery
disease
20 (15.5) 45 (28.5) 15 (27.2)
Atrial ﬁbrillation 23 (17.8) 45 (28.5) 14 (25.4)
Diabetes mellitus 21 (16.2) 26 (16.5) 4 (7.3)
Hematologic disorders 6 (4.6) 9 (6.3) 1 (1.8)
Table 5
Postoperative results. Complications and recurrence rate of chronic subdural he-
matoma in correlation with medical problems, initial Glasgow Coma Scale (GCS)
score and Glasgow Outcome Scale (GOS) at discharge.
No. of patients (n ¼ 342) Recurrent
(n ¼ 41)
Not recurrent
(n ¼ 301)
p
Male sex, % 84.3 72.5 0.23
Age, mean  SD, y 76  13.0 72  13.6 0.72
Medical history, %
Cardiovascular disease 55.6 58.3 0.65
Diabetes mellitus 27.5 12.3 0.01*
Preoperative anticoagulant and/or
antithrombotic medication
51.5 54.0 0.97
Initial GCS score n (%) <0.001*
GCS < 8 28 (68.3) 4 (1.33)
GCS 8e12 9 (21.9) 42 (13.9)
GCS > 12 4 (9.7) 255 (84.7)
GOS at discharge n (%) <0.001*
(1) Good recovery 0 258 (85.7)
(2) Moderate disability 0 27 (8.9)
(3) Severe disability 34 (83.0) 8 (2.66)
(4) PVS 4 (9.8) 3 (0.99)
(5) Death 3 (7.3) 5 (1.66)
Postoperative complications, % 14.63 3.98 0.001*
*Signiﬁcant.
INR ¼ international normalized ratio; IQR ¼ interquartile range; PVS ¼ persistent
vegetative state.
S.-Y. Cheng et al.40clinical results are comparable to the data by Ramachandran and
Hegde17. Gelabert-Gonzáles et al3 analyzed 1000 patients with
CSDH, 559 of whom were aged >70 years. In their study, the
favorable outcome was achieved in 86.1% overall without further
differentiation with respect to age.4.3. Anticoagulant or antithrombotic therapy and recurrence
Anticoagulant/antithrombotic therapy is a known predisposing
factor for occurrence and recurrence of CSDH18. In the current
study, the recurrence rate was higher in patients with underlying
bleeding diathesis. Mori and Maeda19 reported a recurrence rate of
18.5% in patients receiving anticoagulant agents. In our series, the
use of anticoagulant or thrombolytic agent on admission were
found at a relatively low rate in 14.9% of the patients, which might
be a result of low rate of recurrence (11.9%) in the study. However,
there was no signiﬁcant relationship between preoperative anti-
coagulant/antithrombotic therapy and recurrence in data.
In this study, the patients with concomitant medical problems,
lower GCS scores on admission, and higher GOS at discharge were
found to have a higher recurrence. This indicates that an observed
correlation is apparent between preoperative status, concomitant
diseases, and the outcome.Postoperative outcome of CSDH
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Fig. 2. Neurological status measured by Glasgow Outcome Scale (GOS) at discharge
showed postoperative outcome between the age groups (% of total number of cases).
Favorable and unfavorable outcomes were deﬁned as Glasgow Outcome Scale (GOS)
scores of 1e2 and 3e5, respectively. CSDH ¼ chronic subdural hematoma.4.4. Complications
Elderly patients are usually at higher risk of suffering from hy-
pertension, coronary artery disease, diabetes mellitus, or atrial
ﬁbrillation (Table 3). The concomitant diseases may increase the
incidence of complications during the course of surgical
treatment20,21.
Themost frequent complication in our series was acute subdural
hematoma, (1.75%) followed by stroke (1.17%) and infection (0.88%).
Mori and Maeda19 reported on 500 patients with an overall
complication rate of 5.4%. Ernestus et al22 reported on 104 patients
with CSDH. Acute bleeding in the subdural space was observed in
11 patients (11%). All of the patients with acute subdural hemor-
rhage were pretreated with anticoagulants22. Therefore, the indi-
cation for these medications should be carefully evaluated and
controlled.
Other surgical complications such as postoperative intracerebral
hemorrhage were also noted in the study. The cause remains un-
clear and the mechanism of this occurrence is still controversial.
Rapid perioperative parenchymal shift causing direct vascular
damage or sudden increase in intracranial blood ﬂow combined
with defective vascular autoregulation may be responsible22e24.
Extracranial complications are associated with age and pre-
morbid conditions, themost dangerous of thesewere postoperative
pneumonia or pulmonary embolism20. In our series, two patients
(0.58%) did not survive this complication despite adequate antibi-
otic therapy. Cardiac problems were observed in 11 patients (3.2%)
and septic complications in three (0.88%). The average stay in the
hospital was 7.9 days, ranging from 3 days to 51 days.
4.5. Mortality rates
Mortality rates are reported to be closely related to complica-
tions in the literature17. In the current study, mortality was asso-
ciatedwith a higher age, lower GCS scores on admission, and higher
GOS postoperatively. It indicated a result of poor outcome, recur-
rence, complications, and multiple related concomitant diseases. In
our study, the overall mortality rate of the elderly patients was
2.34%, which is comparable to themajority of published studies16,17.
However, older age was not related to increased mortality in the
present study.
4.6. GCS and GOS as predictors of recurrence and mortality
Several studies have established that GCS and GOS are corre-
latedwith the outcome and recurrence of CSDH7,9. The results show
that GOS at discharge has a strong association with CSDH recur-
rence and GCS scores on admission were signiﬁcantly lower in the
recurrence group7,9. In our study, we found the associations be-
tween GCS, GOS, and recurrence, which are consistent with the
data in the literature7e9, indicate that lower GCS scores on admis-
sion and higher GOS scores at discharge were signiﬁcantly associ-
ated with higher recurrence rates (p < 0.001).
Although the neurological state at the time of diagnosis has
been reported as the most important prognostic factor25,26, there is
still dispute in some studies4. The inﬂuence of age on the morbidity
and mortality is controversial and several studies have shown no
relationship with age27. Increasing age was signiﬁcantly associated
with mortality in a multivariate model, but its contribution was
small compared with the level of consciousness28.
CSDH is one of the most frequent types of intracranial hemor-
rhage. There is a trend towards a higher risk of trauma in the
elderly, which is usually associated with anticoagulation or
antithrombotic therapy. In general, morbidity and mortality in-
crease with advancing age, and the major contributing factor to a
Chronic Subdural Hematoma in the Elderly 41poorer prognosis is frailty and the presence of multiple concomi-
tant medical problems28,29. Therefore, the indication for medica-
tion should be carefully evaluated and controlled in elderly
patients.
The present study had several limitations. First, the sample size
was relatively small and the analysis was a retrospective single-
center experience. In addition, the follow-up with outcome
assessment was performed in a relatively short period after
discharge. It was conceivable that the full extent of recurrences or
later complications may not have been captured. Our data could
only illustrate the condition of patients in northern Taiwan. Thus,
further studies with a larger prospective, population-based sample
sizes will be needed to conﬁrm the results obtained so far.
In conclusion, the present study indicated that an observed
correlation is apparent between preoperative status, concomitant
diseases, and outcome. Burr-hole craniostomy should be the
method of choice for surgical treatment of CSDH. The recognition
and attention to prevent perioperative complications may improve
the beneﬁt for elderly patients with CSDH.Acknowledgments
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